Channelrhodopsins are light activated ion channels used extensively over the past decade to probe the function of genetically defined neuronal populations and distinct neural circuits with high temporal and spatial precision. The widely used Channelrhodopsin-2 variant (ChR2) is an excitatory opsin that undergoes conformational changes in response to blue light, allowing non-selective passage of protons and cations across the plasma membrane thus leading to depolarization. In the addiction neuroscience field, opsins such as ChR2 provide a means to disambiguate the overlapping circuitry involved in mediating the reinforcing and aversive effects of drugs of abuse as well as to determine the plasticity that can occur in these circuits during the development of dependence. Although ChR2 has been widely used in animal models of drug and alcohol self-administration, direct effects of drugs of abuse on ChR2 function may confound its use and lead to misinterpretation of data. As a variety of neuronal ion channels are primary targets of various drugs of abuse, it is critical to determine whether ChR2-mediated currents are modulated by these drugs. In this study, we performed whole-cell electrophysiological recordings in HEK293 cells expressing the commonly used ChR2(H134R) variant and examined the effects of various drugs of abuse and other commonly used agents on light-induced currents. We found no differences in ChR2-mediated currents in the presence of 30 mM nicotine, 30 mM cocaine, 100 mM methamphetamine or 3 mM toluene. Similarly, ChR2 currents were insensitive to 30 mM ethanol but higher concentrations (100e300 mM) produced significant effects on the desensitization and amplitude of light-evoked currents. Tetrahydrocannabinol (1e10 mM) and morphine (30e100 mM) significantly inhibited ChR2 currents while the cannabinoid receptor antagonist AM-251 had no effect. The sodium channel blocker tetrodotoxin (5 mM) and the generic channel blocker/contrast agent gadolinium chloride (10 mM) also reduced ChR2 currents while the divalent ion magnesium (10 mM) had no effect. Together, the results from this study highlight the importance of conducting appropriate control experiments when testing new compounds in combination with optogenetic approaches.
Introduction
The advent of optogenetic tools has provided unprecedented control over neuronal firing with millisecond temporal resolution and cell-type specific precision (Boyden et al., 2005) . Over the past decade, optogenetic tools have been extensively used to disentangle the complex circuitry of the mammalian CNS allowing for a greater understanding of the physiology of distinct neural circuits and their direct roles in behavior. Importantly, these tools have provided valuable insight into the development of pathological changes associated with neurological disorders. For example, optogenetic approaches have been used extensively within the substance abuse field to investigate the development of addictive disorders. Some optogenetic studies have examined the acute effects of drugs on distinct cell populations (Adrover et al., 2014) , the allostatic adaptations induced by chronic drug exposure (Melchior and Jones, 2017) and the circuitry associated with drug withdrawal (Kaufling and Aston-Jones, 2015) . Furthermore, behavioral studies using optogenetics have illuminated the role of specific circuits in controlling drug seeking (Bass et al., 2013; Chen et al., 2013) , consumption (Millan et al., 2017) and withdrawal related behaviors (Wang et al., 2016) . However, the excitement surrounding the potential of optogenetic approaches within the substance abuse field has progressed without an important control experiment to determine if the substances themselves alter ChR2 function. These interactions could potentially alter the interpretation of optogenetic studies and warrant further examination.
Channelrhodopsin-2 (ChR2) is a seven-transmembrane lightactivated cation channel which produces inward currents upon illumination resulting in neuronal depolarization (Boyden et al., 2005) . Activation of ChR2 with blue light initiates a series of conformational changes, referred to as its photocycle, which allows for a time-locked conductance of various mono-and divalent cations including sodium, potassium and calcium with a high selectivity for protons (Nagel et al., 2003) . During the photocycle, the channel transitions through at least three distinct conformational phases; the activated fully open state, a desensitized partially conducting state, and an inactivated closed state (Nagel et al., 2003) . Considering that a variety of different drugs of abuse are known to influence the gating properties of other ion channels it is possible that ChR2 function could likewise be influenced. These drugs could potentially interfere with any stage in the photocycle producing effects on total current passage, rise time, decay time or desensitization of these currents. In order to confidently proceed with optogenetic studies in the substance abuse field it will be important to examine drug effects on the amplitude and kinetics of ChR2 currents.
One issue with determining the direct effects of drugs on ChR2 function lies in the fact that these drugs are known to produce a variety of effects on endogenous neuronal proteins, making it difficult to distinguish direct effects on ChR2 from off-target effects. In order to minimize this issue, we have utilized HEK-293 cells which have a comparatively lower expression level of ionotropic receptors, thus allowing for a more pure examination of ChR2 function. Furthermore, considering the relatively small size of HEK293 cells, 20e30 mm in length, drugs can be directly applied to the entire cell surface in the sub-second time scale by using a local perfusion system (Thomas and Smart, 2005) . Therefore, in these studies we have transfected HEK293 cells with ChR2 and examined the amplitude, desensitization and channel kinetics of light evoked responses during exposure to a variety of different substances of abuse as well as several other substances that are commonly used in neuroscience research.
Methods/materials
2.1. HEK293 cell maintenance and receptor expression HEK293 cells were obtained from American Type Culture Collection (Manassas, VA) and grown according to the provided protocol. In brief, cells were cultured in Dulbecco's Minimum Eagle Medium (DMEM, Life Technologies, Grand Island, NY) supplemented with 10% fetal calf serum (Hyclone, Logan, Utah) and grown at 37 C in a 5% CO2 environment. Twenty-four hours following plating of low-density cultures (approximately 5 Â 10 4 cells per dish) onto 35 mm dishes coated with poly-l-ornithine, cells were transfected with 1 mg of pcDNA3.1/hChR2(H134R)-EYFP (AddGene, Plasmid #20940) using the Lipofectamine 2000 reagent (Life Technologies, Grand Island, NY). Cells were used for electrophysiological recordings 24e48 h following transfection.
Whole cell electrophysiology
Before recording, cells were washed thoroughly with external solution containing (in mM): NaCl 135, KCl 5.4, CaCl 2 1.8, HEPES 5, glucose 10 (pH adjusted to 7.4 with NaOH and osmolarity adjusted to 315e325 mOsm/kg with sucrose). Patch electrodes (tip resistance 3e6 MU) were fabricated from thick-walled borosilicate glass and filled with internal solution composed of (in mM): CsCl 140, Mg-ATP 2, Na-GTP 0.3, MgCl 2 2, HEPES 10, EGTA 1 (pH was adjusted to 7.2 with CsOH and osmolarity was adjusted to 290e300 mOsm/ kg with sucrose). All internal solutions used for each experiment were from frozen stocks. All drug solutions were prepared fresh for each experiment in the same batch of external solution used that day. eGFP expressing cells were identified using a 470 nm LED (Thorlabs, Sparta, NJ) attached to an Olympus IX50 inverted microscope. A perfusion apparatus (Warner Instruments, Hamden, CT; SF-77A) consisting of a 3 barrel array (barrel ID 0.6 mm) was used to switch between control solutions and drug-containing solutions applied directly to the cell surface. Baseline ChR2 gated currents were evoked with a series of nine 470 nm light pulses (1 Hz frequency, 5 msec pulse width). The stimulation protocol was then repeated during exposure of the cells to the experimental drug. Following washout of the drug, a final series of light pulses were applied to the patched cell. All recordings were made at room temperature. Data were acquired using an Axopatch 200B amplifier (Axon Instruments, Union City, CA) in whole-cell voltage-clamp mode. Cells were voltage clamped at À60 mV and current records were filtered at 1 kHz (8-pole Bessel filter) and digitized at 2 kHz using an ITC-16 interface (Instrutech Corp., Port Washington, NY).
Drugs
All drugs were prepared daily using the same batch of external solution used in the recordings to eliminate potential differences related to batch of recording solution. 200-proof ethanol was purchased from Decon Laboratories. (À)-Nicotine, toluene, magnesium chloride, tetrodotoxin, and gadolinium(III) chloride were all purchased from Sigma. THC was put into solution using <0.1% dimethyl sulfoxide and tween 80.
Analysis
Data were collected and analyzed using Axograph software (AxographX, New South Wales). Statistical analysis was performed using GraphPad Prism 7 software. Repeated measures one-way ANOVAs were used to identify statistically significant differences across treatments, while Dunnett's post-test was used to compare baseline to drug values and baseline to wash out values. Comparisons were considered statistically significant when p-values were <0.05. Values for desensitization were determined by dividing the peak amplitude of the ninth pulse in the 1 Hz train by the peak amplitude of the first pulse in the train. Decay times were determined by fitting a 2-phase exponential function beginning at the peak of the current and ending when the event returned to prestimulus levels. The fast early phase of this current is denoted as T1 and the slow later phase is denoted as T2.
Results and discussion

Psychostimulants: cocaine and methamphetamine
Optogenetic approaches have been extensively used in studies examining the effects of cocaine and methamphetamine on reward-related circuitry in both in-vivo (Lobo et al., 2010; Bonaventura et al., 2017; Warlow et al., 2017) and in-vitro settings (Adrover et al., 2014; Vickrey et al., 2009) . Direct actions of these drugs on ChR2 function would potentially confound interpretation of data collected from drug and control groups. To address this concern we examined the direct effects of cocaine and methamphetamine on ChR2 function using concentrations that are predicted to be within the limits used in most studies. As shown in (100 mM) also had no significant effect on peak amplitude ( Fig. 1 B 1 . Fig. 1 B 2 . p ¼ 0.42), rise time ( Fig. 1 B 3 . p ¼ 0.63), fast decay ( Fig. 1 B 4 . p ¼ 0.46) or slow decay ( Fig. 1 B 5 . p ¼ 0.86) of ChR2 mediated currents. Considering that 4 mM concentrations of cocaine (Jones and Holmgren, 2014) and between 1 and 120 mM methamphetamine (McIntyre et al., 2013) have been found in post-mortem blood samples from deaths related to overdose, these results suggest ChR2 function is unlikely to be affected Fig. 1 . Effect of the psychostimulants cocaine and methamphetamine on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 30 mM cocaine (A) or 100 mM methamphetamine (B) followed by a washout. Individual sub-panels show effect of drug on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), drug (Red) and washout (Gray) conditions. Data are mean ± SEM (n ¼ 8 cocaine, n ¼ 6 methamphetamine). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) by concentrations of cocaine or methamphetamine normally generated during self-administration studies of psychostimulants.
Ethanol
Optogenetic approaches have likewise been used in a number of in-vivo (Bass et al., 2013; Mikhailova et al., 2016) and in-vitro (Ji et al., 2015; Patton et al., 2016) studies to determine which neural circuits underlie specific ethanol related behaviors and how ethanol acutely modulates neuronal function. To determine if ethanol directly modulates the kinetics of ChR2, we recorded lightevoked currents during exposure to 30 mM, 100 mM and 300 mM ethanol. Here, we found that 30 mM ethanol did not significantly alter the peak amplitude (Fig. 2 A 1 . p ¼ 0.31, n ¼ 14), desensitization ( Fig. 2 A 2 . p ¼ 0.64), 10e90 rise time (Fig. 2 A 3 . p ¼ 0.76), fast decay (Fig. 2 A 4 . p ¼ 0.44) or slow decay (Fig. 2 A 5 . p ¼ 0.56) of ChR2 mediated currents. At a concentration of 100 mM, ethanol also did not significantly alter the peak amplitude (Fig. 2 B 1 . p ¼ 0.36, n ¼ 20), 10e90 rise time (Fig. 2 B 3 . p ¼ 0.06), fast decay (Fig. 2 B 4 . p ¼ 0.62) or slow decay (Fig. 2 B 5 . p ¼ 0.12) of ChR2 mediated currents. However, 100 mM ethanol significantly increased the extent of desensitization of ChR2 currents over a 10 s 1-Hz train ( Fig. 2 B 2 . p ¼ 0.0005, Dunnett's posttest significant at 100 mM Ethanol p ¼ 0.0016, but not wash out p ¼ 0.96). At the highest concentration of ethanol tested (300 mM) both peak amplitude (Fig. 2 C 1 . p ¼ 0.004, n ¼ 22, Dunnett's posttest was significant for 300 mM Ethanol p ¼ 0.0019 but not wash out p ¼ 0.20) and desensitization ( Fig. 2 C 2 . p < 0.0001, Dunnett's posttest significant at 300 mM Ethanol p ¼ 0.0005, but not wash out p ¼ 0.26) of ChR2 currents were affected, while there was no effect on rise time (Fig. 2 C 3 . p ¼ 0.17) fast decay (Fig. 2 C 4 . p ¼ 0.27) or slow decay (Fig. 2 C 5 . p ¼ 0.89) of ChR2 currents. In humans, the legal limit of intoxication is approximately 17 mM (0.08% blood ethanol concentration) and higher levels (44e66 mM; 0.2e0.3% BEC) are not uncommon following binge drinking. The concentrations of ethanol observed to affect ChR2 function in this study (>100 mM) are typically lethal in non-alcohol dependent subjects although BECs in this range have been reported in highly tolerant individuals. These results suggest that although physiologically relevant concentrations of ethanol do not appear to significantly affect ChR2 function, higher concentrations that may be used in in vitro studies to fit a dose response curve could skew results towards exaggerated levels of inhibition.
Cannabinoids
Optogenetic approaches have additionally been used to examine the modulatory role of cannabinoids in distinct cell populations and neurocircuitry. Furthermore, the CB1 selective antagonist AM 251 is commonly used in optogenetic studies to determine the receptor subtype responsible for circuit specific cannabinoid effects (Mateo et al., 2017; Kiritoshi et al., 2016) . However, it is unclear if exogenous cannabinoids like tetrahydrocannabinol (THC) or antagonists like AM 251 produce direct effects on channelrhodopsin-2 function. Therefore, we have examined the effects of THC and AM 251 on ChR2-mediated currents. There are many variables that contribute to brain and plasma THC concentrations following marijuana smoking. A study in 2007 showed individuals with peak plasma concentrations of~850 nM after smoking a single cannabis cigarette containing 3.55% THC (Huestis, 2007) ; however, concentrations in the low mM range have been reported following high dose oral THC administration (Lee et al., 2013) . Additionally, invitro experiments in brain slice preparations often use higher concentrations of THC (Hoffman and Lupica, 2013) . Accordingly, we have tested THC at low (1 mM) and high (100 mM) concentrations.
Here we have found that 1 mM THC significantly inhibits the amplitudes of ChR2 currents (Fig. 3 A 1 . RM 1-Way ANOVA, p ¼ 0.0027, n ¼ 13, Dunnett's posttest was significant for 1 mM THC p ¼ 0.0011 but not wash out p ¼ 0.34). However, 1 mM THC did not alter desensitization ( Fig. 3 A 2 . RM 1-Way ANOVA, p ¼ 0.33), rise time (Fig. 3 A 3 . RM 1-Way ANOVA, p ¼ 0.40), fast decay time (Fig. 3 A 4 . RM 1-Way ANOVA, p ¼ 0.32) or slow decay time (Fig. 3 A 5 . RM 1-Way ANOVA, p ¼ 0.96). Similarly, 100 mM THC significantly inhibited ChR2 amplitudes but the effect did not completely wash out (Fig. 3 B 1 . RM 1-Way ANOVA, p ¼ 0.0003, n ¼ 18, Dunnett's posttest was significant for 100 mM THC p ¼ 0.0011 and for wash out p ¼ 0.031). Furthermore, 100 mM THC did not significantly alter ChR2 desensitization (Fig. 3 B 2 . RM 1-Way ANOVA, p ¼ 0.12), rise times (Fig. 3 B 3 . RM 1-Way ANOVA, p ¼ 0.40), fast decay time (Fig. 3  B 4 . RM 1-Way ANOVA, p ¼ 0.32) or slow decay time (Fig. 3 B 5 . RM 1-Way ANOVA, p ¼ 0.96). Interestingly, 1 mM AM 251, a CB1 antagonist, had no effects on the amplitude (Fig. 3 C 1 . RM 1-Way ANOVA, p ¼ 0.58, n ¼ 11), desensitization ( Fig. 3 C 2 . RM 1-Way ANOVA, p ¼ 0.35), 10e90 rise times (Fig. 3 C 3 . RM 1-Way ANOVA, p ¼ 0.80), fast decay times (Fig. 3 C 4 . RM 1-Way ANOVA, p ¼ 0.12) or slow decay times (Fig. 3 C 5 . RM 1-Way ANOVA, p ¼ 0.57) of ChR2 currents ChR2-mediated currents. These results suggest that caution should be used developing optogenetic studies using cannabinoids. Potentially, other optogenetic proteins or different cannabinoid agonists could strengthen the experimental design, but would require further controls to be sure.
Morphine
Channelrhodopsin-2 has been used in in-vitro studies to examine morphine induced changes in synaptic plasticity (Hearing et al., 2016; Zhu et al., 2016) . Additionally, a recent in-vivo study used morphine in conjunction with optogenetics to show that activation of Ab fibers increases pain sensitivity that is resistant to morphine, in a model of peripheral nerve injury (Tashima et al., 2018) . However, it is unclear if morphine produces direct effects on ChR2 currents which could produce confounding effects in these types of studies. Therefore, we examined the effects of morphine on ChR2 currents at two concentrations: low (30 mM) and high (100 mM). Here we found that 30 mM morphine inhibited ChR2 peak amplitudes (Fig. 4 A 1 . RM 1-Way ANOVA, p ¼ 0.0038, n ¼ 15, Dunnett's posttest was significant for 1 mM Morphine p ¼ 0.02 but not wash out p ¼ 0.14), but did not alter ChR2 desensitization (Fig. 4 A 2 . RM 1-Way ANOVA, p ¼ 0.33), 10e90 rise times (Fig. 4 A 3 . RM 1-Way ANOVA, p ¼ 0.11), fast decay times (Fig. 4 A 4 . RM 1-Way ANOVA, p ¼ 0.56) or slow decay times (Fig. 4 A 5 . RM 1-Way ANOVA, p ¼ 0.83) of ChR2 currents. Likewise, 100 mM morphine significantly inhibited the peak amplitude of ChR2 currents (Fig. 4 B 1 . RM 1-Way ANOVA, p ¼ 0.026, n ¼ 7, Dunnett's posttest was significant for 100 mM Morphine p ¼ 0.019 but not wash out p ¼ 0.54), but did not alter the desensitization (Fig. 4 B 2 . RM 1-Way ANOVA, p ¼ 0.124), 10e90 rise times (Fig. 4 B 3 . RM 1-Way ANOVA, p ¼ 0.73), -fast decay times (Fig. 4 B 4 . RM 1-Way ANOVA, p ¼ 0.26) or slow decay times (Fig. 4 B 5 . RM 1-Way ANOVA, p ¼ 0.71) of ChR2 currents. Accordingly, future experiments using optogenetics and morphine should include appropriate controls to reduce this inhibitory action (see Fig. 4 ).
Other drugs of abuse: toluene and nicotine
Toluene is a commonly used industrial solvent that is frequently inhaled for its intoxicating effects. In vitro studies show that toluene has significant effects on a variety of ligand-gated and voltage-gated ion channels with effects occurring as low as 170 mM (Cruz et al., 2014) . Although ChR2 has not yet been used to study Fig. 2 . Effect of Ethanol on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 30 mM (A), 100 mM (B) or 300 mM ethanol (C) followed by a washout. Individual sub-panels show effect of ethanol on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), ethanol (Red) and washout (Gray) conditions. Data are mean ± SEM (30 mM n ¼ 14; 100 mM n ¼ 20; 300 mM n ¼ 22). Symbols: (** ¼ main effect p < 0.01, *** ¼ main effect p < 0.001, **** ¼ main effect p < 0.0001, ## ¼ Dunnett's posttest p < 0.01, ### Dunnett's posttest p < 0.001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Fig. 3 . Effect of Cannabinoids on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 1 mM THC (A), 100 mM THC (B) or 1 mM AM 251 (C) followed by a washout. Individual sub-panels show effect of drugs on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), drug (Red) and washout (Gray) conditions. Data are mean ± SEM (1 mM THC n ¼ 13; 100 mM THC n ¼ 18; 1 mM AM 251 n ¼ 11). Symbols: (** ¼ main effect p < 0.01, *** ¼ main effect p < 0.001, # ¼ Dunnett's posttest p < 0.05, ## ¼ Dunnett's posttest p < 0.01). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) the acute effects of this drug in vivo, it is likely that future studies will use this approach. Accordingly, we examined the effects of toluene on ChR2 channels expressed in HEK293 cells. Toluene (3 mM) had no significant effect on the amplitude (Fig. 5 A 1 . p ¼ 0.60, n ¼ 6), desensitization ( Fig. 5 A 2 . p ¼ 0.29), rise time (Fig. 5 A 3 . p ¼ 0.47), fast decay (Fig. 5 A 4 . p ¼ 0.55) or slow decay (Fig. 5 A 5 . p ¼ 0.78) of ChR2 mediated currents. As this concentration of toluene is higher than that achieved during voluntary inhalation of this solvent, <1 mM (Thiesen et al., 2007) , ChR2 function is unlikely to be impacted during in vivo studies of toluene action. Fig. 4 . Effect of Morphine on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 30 mM Morphine (A) or 100 mM Morphine (B) followed by a washout. Individual sub-panels show effect of morphine on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), morphine (Red) and washout (Gray) conditions. Data are mean ± SEM (30 mM n ¼ 15, 100 mM n ¼ 7). Symbols: (* ¼ main effect p < 0.05, ** ¼ main effect p < 0.01, # ¼ Dunnett's posttest p < 0.05). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
A recent study showed that nicotine inhibited ChR2 elicited dopamine release in the striatum (Wang et al., 2014) ; however, this study did not determine whether nicotine may have had any direct effects on ChR2 conductance. Here we show that a relatively high concentration of nicotine, 30 mM, did not have any significant effects on the amplitude (Fig. 5 B 1 . p ¼ 0.24, n ¼ 10), desensitization ( Fig. 5 B 2 . p ¼ 0.63), rise time (Fig. 5 B 3 . p ¼ 0.41), fast decay (Fig. 5  B 4 . p ¼ 0.56), or slow decay (Fig. 5 B 5 . p ¼ 0.73) of ChR2 mediated Fig. 5 . Effects of other drugs of abuse on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 3 mM Toluene (A) or 30 mM Nicotine (B) followed by a washout. Individual sub-panels show effect of drugs on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), drug (Red) and washout (Gray) conditions. Data are mean ± SEM (3 mM Toluene n ¼ 6; 30 mM Nicotine n ¼ 10). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
currents. This suggests that ChR2 studies of nicotine action are not likely to be compromised by direct effects of the drug on channel function. Furthermore, since blood nicotine levels in chronic smokers reach <350 nM (Benowitz et al., 1982) it is unlikely that channelrhodopsin-2 function would be affected in selfadministration studies.
Tetrodotoxin
The sodium channel blocker tetrodotoxin (TTX) is commonly used in electrophysiological experiments to prevent the generation of action potentials. Several studies have used TTX in combination with optogenetic tools to identify specific monosynaptic Fig. 6 . Effect of Tetrodotoxin on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 1 mM tetrodotoxin (A) or 5 mM tetrodotoxin (B) followed by a washout. Individual sub-panels show effect of morphine on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), tetrodotoxin (Red) and washout (Gray) conditions. Data are mean ± SEM (1 mM n ¼ 16; 5 mM n ¼ 13). Symbols: (* ¼ main effect p < 0.05, ** ¼ main effect p < 0.01, # ¼ Dunnett's posttest p < 0.05). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Fig. 7 . Effect of the ions MgCl 2 and GdCl 3 on light-evoked ChR2 currents: HEK293 cells expressing ChR2(H134R) were voltage-clamped at À60 mV and exposed to brief pulses of 470 nm light in the absence and presence of 10 mM magnesium chloride (A), 1 mM gadolinium trichloride (B) or 10 mM gadolinium trichloride (C) followed by a washout. Individual sub-panels show effect of ions on current amplitude (1), desensitization (2), 10e90% rise time (3), fast decay time (4) and slow decay time (5). Representative examples from single recordings show responses during the 9 pulse episode (6) and average single response (7) under baseline (Black), ions (Red) and washout (Gray) conditions. Data are mean ± SEM (10 mM magnesium chloride n ¼ 11; 1 mM gadolinium trichloride n ¼ 8). Symbols: (* ¼ main effect p < 0.05, ** ¼ main effect p < 0.01, *** ¼ main effect p < 0.001, # ¼ Dunnett's posttest p < 0.05, ## ¼ Dunnett's posttest p < 0.01). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) projections (Petreanu et al., 2007; Gioia et al., 2016) . In these experiments, TTX was applied in the presence of the potassium channel blocker 4-amino pyridine to eliminate network activity and allow measurement of monosynaptic transmission mediated exclusively by depolarization of ChR2 positive terminals. However, some monosynaptic projections are relatively weak and may be missed if TTX directly impairs ChR2 function. In this study we found that 1 mM TTX had no effect on the amplitude (Fig. 6 A 1 . p ¼ 0.21, n ¼ 16), desensitization (Fig. 6 A 2 . p ¼ 0.52), rise time (Fig. 6 A 3 . p ¼ 0.06), slow decay (Fig. 6 A 4 . p ¼ 0.75) or fast decay (Fig. 6 A 5 . p ¼ 0.30) of ChR2 currents. However, at a higher concentration (5 mM), TTX significantly decreased the peak amplitude (Fig. 6 B 1 . p ¼ 0.004, n ¼ 13, Dunnett's posttest was significant for 5 mM TTX p ¼ 0.014, but not wash out p ¼ 0.724), rise time (Fig. 6 B 3 . p ¼ 0.014, Dunnett's posttest was significant for 5 mM TTX p ¼ 0.0348, but not wash out p ¼ 0.642), and fast decay (Fig. 6 B 4 . p ¼ 0.02, Dunnett's posttest was significant for 5 mM TTX p ¼ 0.0246, but not for wash out p ¼ 0.99) of ChR2 currents while having no significant effects on desensitization (Fig. 6 B 2 . p ¼ 0.83) or slow decay (Fig. 6 B 5 . p ¼ 0.75). These results suggest that studies using TTX/4-AP to evaluate monosynaptic signaling generally should restrict use of TTX to concentrations of 1 mM or less to reduce complications with data interpretation.
Ions: magnesium chloride and gadolinium trichloride
ChR2 is permeable to a variety of monovalent and divalent cations, but not magnesium chloride (Nagel et al., 2003) . As magnesium chloride is a common constituent of artificial cerebrospinal fluid solutions used during combined electrophysiological and optogenetic experiments, we tested whether magnesium interferes with light-activated ChR2 currents. Here we found that 10 mM magnesium chloride had no significant effect on the amplitude (Fig. 7 A 1 . p ¼ 0.24, n ¼ 11), desensitization ( Fig. 7 A 2 . p ¼ 0.22), rise time (Fig. 7 A 3 . p ¼ 0.28), fast decay (Fig. 7 A 4 . p ¼ 0.59) or slow decay (Fig. 7 A 5 . p ¼ 0.82) of ChR2 mediated currents. Accordingly, as the concentration of magnesium chloride in most recording solutions is in the low mM range, the inclusion of this ion should not significantly affect ChR2 currents during optogenetic experiments.
Gadolinium (III) chloride hexahydrate (GdCl 3 ) is a large trivalent metal cation that been shown to inhibit a variety of ion channel subtypes including some calcium channels (Beedle et al., 2002; Szteyn et al., 2015) potassium channels (Hongo et al., 1997) sodium channels (Babinski et al., 2000) transient receptor potential channels (Tousova et al., 2005) and other non-selective cation channels (Cho et al., 2002) . Therefore, we reasoned that GdCl 3 would be a likely candidate to inhibit channelrhodopsin currents. Here we found that a low concentration of GdCl 3 (1 mM) had no significant effect on the amplitude (Fig. 7 B 1 . p ¼ 0.47, n ¼ 8), desensitization ( Fig. 7 B 2 . p ¼ 0.20), rise time (Fig. 7 B 3 . p ¼ 0.71), fast decay (Fig. 7  B 4 . p ¼ 0.46) or slow decay (Fig. 7 B 5 . p ¼ 0.15) of ChR2 mediated currents. However, at 10 mM, GdCl 3 significantly inhibited the amplitude (Fig. 7 C 1 . p ¼ 0.0054, n ¼ 9, Dunnett's posttest was significant for 10 mM GdCl 3 p ¼ 0.015 but not wash out p ¼ 0.17), fast decay (Fig. 7 C 4 . p ¼ 0.02, Dunnett's posttest is significant at 10 mM Gadolinium p ¼ 0.03 but not at wash out p ¼ 0.91) and slow decay (Fig. 7 C 5 . p ¼ 0.0059, Dunnett's posttest is significant at 10 mM GdCl 3 p ¼ 0.0051 but not at wash out p ¼ 0.95) of ChR2 currents while having no significant effects on the rise time (Fig. 7 C 3 . p ¼ 0.13). Interestingly, 10 mM gadolinium largely blocked the desensitization of ChR2 currents observed during repeated stimulations ( Fig. 7 C 2 . p ¼ 0.0004, Dunnett's posttest was significant for 10 mM GdCl 3 p ¼ 0.0044 but not wash out p ¼ 0.98). Accordingly, optogenetic studies examining these various GdCl 3 sensitive ion channels should consider using alternative inhibitors in order to avoid confounded results.
General discussion
There are a couple of important limitations to consider concerning these results. Firstly, these experiments have been conducted in HEK-293 cells rather than in neuronal cells lines that would more closely mimic the cellular environment that ChR2 is generally used in. However, neuronal cell lines express a variety of proteins which are known to be sensitive to drugs of abuse, making it difficult to distinguish direct effects on ChR2 from off-target effects. Considering that HEK-293 cells have a comparatively lower expression level of ionotropic receptors, we reasoned that they were better suited for this study. Secondly, we tested drug concentrations that were generally equal to or higher than brain concentrations attained during self-administration. Potentially, lower doses of these drugs could produce unique effects compared to higher doses; however, we find it much more likely that any effects at lower concentrations would resemble similar but smaller effects relative to the high concentrations. In some instances we included additional higher concentrations which have been used in-vitro. Lastly, the experiments in this study examined the acute effects of drugs on ChR2 mediated currents; however, it is important to note that chronic exposure to these substances may produce different effects. Accordingly, future experiments should examine expression stability of optogenetic and chemogenetic constructs following chronic drug exposure.
Conclusions
Channelrhodopsin-2 appears to be relatively insensitive to physiologically relevant concentrations of alcohol, cocaine, methamphetamine, nicotine and toluene. However, it is possible that channel activity may be impacted by higher concentrations of these drugs or during exposure to drugs in more intact preparations that have more complex signaling pathways. Conversely, channelrhodopsin-2 appears to be sensitive to inhibition by physiologically relevant concentrations of THC and morphine suggesting that different optogenetic proteins may be more suitable for experiments involving these drugs. Future studies using optogenetic and chemogenetic approaches to study drugs of abuse should include these appropriate control experiments to determine if the drugs have any direct effects on these proteins leading to potentially spurious effects. Validation of these techniques for each substance is an important step in providing accurate reproducible studies within the substance abuse field.
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